Invesco Biotechnology & Genome ETF
PBE
PBE
64 hedge funds and large institutions have $52.9M invested in Invesco Biotechnology & Genome ETF in 2017 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 21 increasing their positions, 16 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
64
Holders Change
-4
Holders Change %
-5.88%
% of All Funds
1.6%
Holding in Top 10
β
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
β
New
4
Increased
21
Reduced
16
Closed
6
Calls
β
Puts
β
Net Calls
β
Net Calls Change
β
Top Buyers
Top Sellers
1 |
Stifel Financial
St. Louis,
Missouri
|
$639K |
2 |
Citadel Advisors
Miami,
Florida
|
$0 |
3 |
UBS Group
Zurich,
Switzerland
|
$4.26M |
4 |
Bank of America
Charlotte,
North Carolina
|
$5.09M |
5 |
LPL Financial
San Diego,
California
|
$1.92M |